275 related articles for article (PubMed ID: 21918425)
1. Genetic variation, β-blockers, and perioperative myocardial infarction.
Nagele P; Liggett SB
Anesthesiology; 2011 Dec; 115(6):1316-27. PubMed ID: 21918425
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
Zhou SF
Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
[TBL] [Abstract][Full Text] [Related]
3. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
4. Contemporary personalized β-blocker management in the perioperative setting.
Oprea AD; Wang X; Sickeler R; Kertai MD
J Anesth; 2020 Feb; 34(1):115-133. PubMed ID: 31637510
[TBL] [Abstract][Full Text] [Related]
5. The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.
Chan SW; Hu M; Tomlinson B
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):767-90. PubMed ID: 22621216
[TBL] [Abstract][Full Text] [Related]
6. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users.
Bijl MJ; Visser LE; van Schaik RH; Kors JA; Witteman JC; Hofman A; Vulto AG; van Gelder T; Stricker BH
Clin Pharmacol Ther; 2009 Jan; 85(1):45-50. PubMed ID: 18784654
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of beta-blockers.
Shin J; Johnson JA
Pharmacotherapy; 2007 Jun; 27(6):874-87. PubMed ID: 17542770
[TBL] [Abstract][Full Text] [Related]
9. Variations in pharmacology of beta-blockers may contribute to heterogeneous results in trials of perioperative beta-blockade.
Badgett RG; Lawrence VA; Cohn SL
Anesthesiology; 2010 Sep; 113(3):585-92. PubMed ID: 20693881
[TBL] [Abstract][Full Text] [Related]
10. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery.
Blessberger H; Lewis SR; Pritchard MW; Fawcett LJ; Domanovits H; Schlager O; Wildner B; Kammler J; Steinwender C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013438. PubMed ID: 31556094
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery.
Mostafaie K; Bedenis R; Harrington D
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006342. PubMed ID: 25879091
[TBL] [Abstract][Full Text] [Related]
12. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade.
Lindenauer PK; Fitzgerald J; Hoople N; Benjamin EM
Arch Intern Med; 2004 Apr; 164(7):762-6. PubMed ID: 15078646
[TBL] [Abstract][Full Text] [Related]
13. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD004476. PubMed ID: 29533470
[TBL] [Abstract][Full Text] [Related]
14. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
[TBL] [Abstract][Full Text] [Related]
15. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.
Boersma E; Poldermans D; Bax JJ; Steyerberg EW; Thomson IR; Banga JD; van De Ven LL; van Urk H; Roelandt JR;
JAMA; 2001 Apr; 285(14):1865-73. PubMed ID: 11308400
[TBL] [Abstract][Full Text] [Related]
16. Benefits and risks associated with beta-blocker prophylaxis in noncardiac surgery.
White CM; Talati R; Phung OJ; Baker WL; Reinhart K; Sedrakyan A; Kluger J; Coleman CI
Am J Health Syst Pharm; 2010 Apr; 67(7):523-30. PubMed ID: 20237379
[TBL] [Abstract][Full Text] [Related]
17. Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol.
Lymperopoulos A; McCrink KA; Brill A
Curr Drug Metab; 2015; 17(1):30-6. PubMed ID: 26537419
[TBL] [Abstract][Full Text] [Related]
18. Perioperative β-blocker use: what is new in 2020?
Wang X; Fernandez Robles C; Kertai MD
Curr Opin Anaesthesiol; 2020 Jun; 33(3):417-422. PubMed ID: 32324663
[TBL] [Abstract][Full Text] [Related]
19. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing cardiac surgery.
Blessberger H; Lewis SR; Pritchard MW; Fawcett LJ; Domanovits H; Schlager O; Wildner B; Kammler J; Steinwender C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013435. PubMed ID: 31544227
[TBL] [Abstract][Full Text] [Related]
20. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery.
London MJ; Hur K; Schwartz GG; Henderson WG
JAMA; 2013 Apr; 309(16):1704-13. PubMed ID: 23613075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
